Abstract
Bacampicillin is a new oral prodrug which is rapidly converted to ampicillin during absorption from the gastrointestinal tract. High serum peaks of ampicillin are obtained. Bacampicillin orally was compared pharmacokinetically with parenteral ampicillin (intravenously and intramuscularly). A cross-over study on healthy volunteers showed that ampicillin concentrations after equimolar doses of bacampicillin orally and ampicillin intramuscularly were of the same order. The mean of the individual peak values (regardless of time of occurrence) after a dose of 800 mg of bacampicillin was 13.1 ± 3.8 μg/ml. Absorption rates of the two doses were similar, as were their distribution volumes (approximately 25% of the body weight). Bioavailability was 87% for bacampicillin, compared to 71% for ampicillin.
Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bergan T., Oydvin B. Microbiological assay of josamycin. Acta Pathol Microbiol Scand B Microbiol Immunol. 1972;80(1):101–106. doi: 10.1111/j.1699-0463.1972.tb00134.x. [DOI] [PubMed] [Google Scholar]
- Bodin N. O., Ekström B., Forsgren U., Jalar L. P., Magni L., Ramsay C. H., Sjöberg B. Bacampicillin: a new orally well-absorbed derivative of ampicillin. Antimicrob Agents Chemother. 1975 Nov;8(5):518–525. doi: 10.1128/aac.8.5.518. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Doluisio J. T., LaPiana J. C., Dittert L. W. Pharmacokinetics of ampicillin trihydrate, sodium ampicillin, and sodium dicloxacillin following intramuscular injection. J Pharm Sci. 1971 May;60(5):715–719. doi: 10.1002/jps.2600600511. [DOI] [PubMed] [Google Scholar]
- EICKHOFF T. C., KISLAK J. W., FINLAND M. SODIUM AMPICILLIN: ABSORPTION AND EXCRETION OF INTRAMUSCULAR AND INTRAVENOUS DOSES IN NORMAL YOUNG MEN. Am J Med Sci. 1965 Feb;249:163–171. [PubMed] [Google Scholar]
- Hultberg E. R., Backelin B. Studies on the absorption of pivampicillin and ampicillin. Scand J Infect Dis. 1972;4(2):149–153. doi: 10.3109/inf.1972.4.issue-2.16. [DOI] [PubMed] [Google Scholar]
- Jusko W. J., Lewis G. P. Comparison of ampicillin and hetacillin pharmacokinetics in man. J Pharm Sci. 1973 Jan;62(1):69–76. doi: 10.1002/jps.2600620112. [DOI] [PubMed] [Google Scholar]
- Jusko W. J., Lewis G. P., Schmitt G. W. Ampicillin and hetacillin pharmacokinetics in normal and anephric subjects. Clin Pharmacol Ther. 1973 Jan-Feb;14(1):90–99. doi: 10.1002/cpt197314190. [DOI] [PubMed] [Google Scholar]
- KNUDSEN E. T., ROLINSON G. N., STEVENS S. Absorption and excretion of "Penbritin". Br Med J. 1961 Jul 22;2(5246):198–200. doi: 10.1136/bmj.2.5246.198. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kirby W. M., Kind A. C. Clinical pharmacology of ampicillin and hetacillin. Ann N Y Acad Sci. 1967 Sep 27;145(2):291–297. doi: 10.1111/j.1749-6632.1967.tb50226.x. [DOI] [PubMed] [Google Scholar]
- Knothe H. Der Einfluss von Pivmecillinam auf die Darmflora des Menschen. Arzneimittelforschung. 1976;26(3):427–431. [PubMed] [Google Scholar]
- Loo J. C., Foltz E. L., Wallick H., Kwan K. C. Pharmacokinetics of pivampicillin and ampicillin in man. Clin Pharmacol Ther. 1974 Jul;16(1):35–43. doi: 10.1002/cpt1974161part135. [DOI] [PubMed] [Google Scholar]
- MacLeod C., Rabin H., Ogilvie R., Ruedy J., Caron M., Zarowny D., Davies R. O. Practical concepts of drug absorption, distribution and loss. Can Med Assoc J. 1974 Aug 17;111(4):341–346. [PMC free article] [PubMed] [Google Scholar]
- NAUMANN P. EXPERIMENTELLE UND KLINISCHE UNTERSUCHUNGEN ZUR PARENTERALEN ANWENDUNG VON AMPICILLIN. Dtsch Med Wochenschr. 1965 Jun 11;90:1085–1092. doi: 10.1055/s-0028-1111470. [DOI] [PubMed] [Google Scholar]
- Sjövall J., Magni L., Bergan T. Pharmacokinetics of bacampicillin compared with those of ampicillin, pivampicillin, and amoxycillin. Antimicrob Agents Chemother. 1978 Jan;13(1):90–96. doi: 10.1128/aac.13.1.90. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Steigbigel N. H., McCall C. E., Reed C. W., Finland M. Antibacterial action of "broad-spectrum" penicillins, cephalosporins and other antibiotics against Gram-negative bacilli isolated from bacteremic patients. Ann N Y Acad Sci. 1967 Sep 27;145(2):224–236. doi: 10.1111/j.1749-6632.1967.tb50221.x. [DOI] [PubMed] [Google Scholar]